相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population
A. Handberg et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study
Fariborz Mobarrez et al.
THROMBOSIS RESEARCH (2012)
Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms
Arunima Ghosh et al.
BLOOD (2011)
Risk of Macrovascular Complications in Type 2 Diabetes Mellitus: Endothelial Microparticle Profiles
Keun-Hwa Jung et al.
CEREBROVASCULAR DISEASES (2011)
Impaired Red Blood Cell Deformability in Patients with Coronary Artery Disease and Diabetes Mellitus
S. Keymel et al.
HORMONE AND METABOLIC RESEARCH (2011)
Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile
Latisha Love-Gregory et al.
HUMAN MOLECULAR GENETICS (2011)
The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles
M. J. Alkhatatbeh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: Relationship with oxidative stress
O. Helal et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Involvement of microparticles in diabetic vascular complications
Gala Tsimerman et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients
Michal Chmielewski et al.
CLINICA CHIMICA ACTA (2010)
Quantification of loss of haemoglobin components from the circulating red blood cell in vivo
F. L. A. Willekens et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Atorvastatin Downregulates Monocyte CD36 Expression, Nuclear NF kappa B and TNF alpha Levels in Type 2 Diabetes
Elisabetta Mandosi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
A. Handberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Comparative proteomics of erythrocyte aging in vivo and in vitro
G. J. C. G. M. Bosman et al.
JOURNAL OF PROTEOMICS (2010)
Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
R. Lacroix et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Circulating Endothelial Microparticles in Diabetes Mellitus
A. F. Tramontano et al.
MEDIATORS OF INFLAMMATION (2010)
The Plasma Microparticle Proteome
Kristina M. Little et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Flow cytometric detection of endothelial microparticles (EMP): Effects of centrifugation and storage alter with the phenotype studied
Sabrina H. van Ierssel et al.
THROMBOSIS RESEARCH (2010)
Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36
R. L. SILVERSTEIN
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance
Jose-Manuel Fernandez-Real et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?
S. Robert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Enclothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome
Abdelali Agouni et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Erythrocyte vesiculation:: a self-protective mechanism?
Frans L. A. Willekens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Microparticles and type 2 diabetes
A.S. Leroyer et al.
DIABETES & METABOLISM (2008)
Microparticles in Health and Disease
Anoop K. Enjeti et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability
Aase Handberg et al.
STROKE (2008)
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
CD36 is a receptor for oxidized high density lipoprotein: Implications for the development of atherosclerosis
Rick F. Thorne et al.
FEBS LETTERS (2007)
Induction of Cd36 expression elicited by fish oil PUFA in spontaneously hypertensive rats
Alfonso Alexander Aguilera et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2006)
Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance
Aase Handberg et al.
CIRCULATION (2006)
Pioglitazone reduces endothelial microparticles in the metabolic syndrome
Katherine Esposito et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Obesity and the white blood cell count: Changes with sustained weight loss
JB Dixon et al.
OBESITY SURGERY (2006)
Circulating procoagulant microparticles in obesity
B Goichot et al.
DIABETES & METABOLISM (2006)
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication
J. Ratajczak et al.
LEUKEMIA (2006)
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels
KT Tan et al.
DIABETIC MEDICINE (2005)
Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy
K Susztak et al.
PLOS MEDICINE (2005)
Elevated plasma endothelial microparticles:: Preeclampsia versus gestational hypertension
VH González-Quintero et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus
M Diamant et al.
CIRCULATION (2002)
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles
F Sabatier et al.
DIABETES (2002)
Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus
S Omoto et al.
DIABETOLOGIA (2002)
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
M Febbraio et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation
E Griffin et al.
NATURE MEDICINE (2001)
CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport
P Gruarin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
Z Mallat et al.
CIRCULATION (2000)
分享论文
